Geneva, May 20 -- International Clinical Trials Registry received information related to the study (NCT06963476) titled 'rTMS as Add on Treatment for Substance Use Disorders' on May 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Yale University
Condition:
Opioid Use
Alcohol Use Disorder
Intervention:
Device: repetitive transcranial magnetic stimulation (rTMS) for AUD
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 2025
Target Sample Size: 80
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06963476
Disclaimer: ...